

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac myofibril assembly (GO:0055003) | 9.69354309 |
| 2 | sarcomere organization (GO:0045214) | 9.52504053 |
| 3 | myofibril assembly (GO:0030239) | 8.37514890 |
| 4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.07294987 |
| 5 | muscle filament sliding (GO:0030049) | 7.64940573 |
| 6 | actin-myosin filament sliding (GO:0033275) | 7.64940573 |
| 7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.37399923 |
| 8 | cardiac muscle contraction (GO:0060048) | 7.35289883 |
| 9 | cardiac muscle tissue morphogenesis (GO:0055008) | 6.63529913 |
| 10 | tricarboxylic acid cycle (GO:0006099) | 6.60720312 |
| 11 | * cardiac muscle cell development (GO:0055013) | 6.56128998 |
| 12 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.54464098 |
| 13 | actin-mediated cell contraction (GO:0070252) | 6.39154481 |
| 14 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 6.36779615 |
| 15 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.29169845 |
| 16 | regulation of actin filament-based movement (GO:1903115) | 6.25363902 |
| 17 | actomyosin structure organization (GO:0031032) | 6.18877920 |
| 18 | * cardiac cell development (GO:0055006) | 6.16166341 |
| 19 | regulation of relaxation of muscle (GO:1901077) | 6.15919676 |
| 20 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.13203121 |
| 21 | cardiac muscle hypertrophy (GO:0003300) | 6.13195297 |
| 22 | adult heart development (GO:0007512) | 6.10552158 |
| 23 | muscle tissue morphogenesis (GO:0060415) | 5.91849313 |
| 24 | heart process (GO:0003015) | 5.91193990 |
| 25 | heart contraction (GO:0060047) | 5.91193990 |
| 26 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.87744437 |
| 27 | regulation of sarcomere organization (GO:0060297) | 5.84679267 |
| 28 | striated muscle hypertrophy (GO:0014897) | 5.79614774 |
| 29 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.75884028 |
| 30 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.73716624 |
| 31 | cardiac ventricle formation (GO:0003211) | 5.64770170 |
| 32 | heart trabecula formation (GO:0060347) | 5.62374721 |
| 33 | striated muscle contraction (GO:0006941) | 5.53574946 |
| 34 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.53132873 |
| 35 | plasma membrane repair (GO:0001778) | 5.39562647 |
| 36 | regulation of skeletal muscle contraction (GO:0014819) | 5.31366543 |
| 37 | regulation of the force of heart contraction (GO:0002026) | 5.28506269 |
| 38 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 5.23570141 |
| 39 | muscle hypertrophy (GO:0014896) | 5.15642047 |
| 40 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.14478255 |
| 41 | regulation of striated muscle contraction (GO:0006942) | 5.10504292 |
| 42 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.99671761 |
| 43 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.96369761 |
| 44 | carnitine shuttle (GO:0006853) | 4.88991491 |
| 45 | actin filament-based movement (GO:0030048) | 4.76772208 |
| 46 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.69264811 |
| 47 | regulation of cardioblast differentiation (GO:0051890) | 4.68898766 |
| 48 | cell communication involved in cardiac conduction (GO:0086065) | 4.68101829 |
| 49 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.67088444 |
| 50 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.67087686 |
| 51 | regulation of membrane repolarization (GO:0060306) | 4.67017532 |
| 52 | regulation of cell communication by electrical coupling (GO:0010649) | 4.64311207 |
| 53 | ATP synthesis coupled proton transport (GO:0015986) | 4.62373092 |
| 54 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.62373092 |
| 55 | atrial septum morphogenesis (GO:0060413) | 4.47483658 |
| 56 | oxidative phosphorylation (GO:0006119) | 4.43429133 |
| 57 | ventricular cardiac muscle cell development (GO:0055015) | 4.43202921 |
| 58 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.31965301 |
| 59 | regulation of cofactor metabolic process (GO:0051193) | 4.31564195 |
| 60 | regulation of coenzyme metabolic process (GO:0051196) | 4.31564195 |
| 61 | response to inactivity (GO:0014854) | 4.31071170 |
| 62 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.30768599 |
| 63 | muscle hypertrophy in response to stress (GO:0003299) | 4.30768599 |
| 64 | cardiac muscle adaptation (GO:0014887) | 4.30768599 |
| 65 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.29528373 |
| 66 | cell communication by electrical coupling (GO:0010644) | 4.25000072 |
| 67 | fatty acid transmembrane transport (GO:1902001) | 4.22834983 |
| 68 | regulation of cardiac muscle contraction (GO:0055117) | 4.17194587 |
| 69 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.17125475 |
| 70 | negative regulation of protein localization to cell surface (GO:2000009) | 4.15736181 |
| 71 | respiratory electron transport chain (GO:0022904) | 4.13382869 |
| 72 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.11825203 |
| 73 | cardiac muscle tissue development (GO:0048738) | 4.11296560 |
| 74 | regulation of ATPase activity (GO:0043462) | 4.08532027 |
| 75 | regulation of ATP catabolic process (GO:1903289) | 4.08532027 |
| 76 | cardiac muscle cell action potential (GO:0086001) | 4.05699896 |
| 77 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.02056194 |
| 78 | electron transport chain (GO:0022900) | 4.01676958 |
| 79 | detection of calcium ion (GO:0005513) | 4.00077769 |
| 80 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.96162558 |
| 81 | relaxation of cardiac muscle (GO:0055119) | 3.96014308 |
| 82 | negative regulation of potassium ion transport (GO:0043267) | 3.93210680 |
| 83 | * regulation of heart rate (GO:0002027) | 3.89683029 |
| 84 | adrenergic receptor signaling pathway (GO:0071875) | 3.85303467 |
| 85 | negative regulation of myotube differentiation (GO:0010832) | 3.83196613 |
| 86 | cellular response to epinephrine stimulus (GO:0071872) | 3.77080863 |
| 87 | positive regulation of action potential (GO:0045760) | 3.72151689 |
| 88 | NADH metabolic process (GO:0006734) | 3.70580427 |
| 89 | response to epinephrine (GO:0071871) | 3.69835623 |
| 90 | * regulation of heart contraction (GO:0008016) | 3.68092719 |
| 91 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.67840842 |
| 92 | trabecula formation (GO:0060343) | 3.65402121 |
| 93 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.65293689 |
| 94 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.65293689 |
| 95 | cardiac conduction (GO:0061337) | 3.64686782 |
| 96 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.59457621 |
| 97 | positive regulation of ATPase activity (GO:0032781) | 3.58922460 |
| 98 | positive regulation of ATP catabolic process (GO:1903291) | 3.58922460 |
| 99 | carnitine transmembrane transport (GO:1902603) | 3.58811469 |
| 100 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.57049926 |
| 101 | * striated muscle cell development (GO:0055002) | 3.56660965 |
| 102 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.54227926 |
| 103 | regulation of muscle system process (GO:0090257) | 3.53492908 |
| 104 | regulation of muscle contraction (GO:0006937) | 3.51336527 |
| 105 | cardiac chamber formation (GO:0003207) | 3.50821775 |
| 106 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.49239559 |
| 107 | 2-oxoglutarate metabolic process (GO:0006103) | 3.46533866 |
| 108 | atrioventricular valve morphogenesis (GO:0003181) | 3.46458954 |
| 109 | regulation of sulfur metabolic process (GO:0042762) | 3.45647622 |
| 110 | muscle contraction (GO:0006936) | 3.42222617 |
| 111 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.40112949 |
| 112 | response to caffeine (GO:0031000) | 3.39119948 |
| 113 | relaxation of muscle (GO:0090075) | 3.36339797 |
| 114 | positive regulation of heart contraction (GO:0045823) | 3.32720659 |
| 115 | positive regulation of cation channel activity (GO:2001259) | 3.32509181 |
| 116 | positive regulation of heart rate (GO:0010460) | 3.28808931 |
| 117 | potassium ion export (GO:0071435) | 3.27352393 |
| 118 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 3.27203110 |
| 119 | positive regulation of sodium ion transport (GO:0010765) | 3.25843874 |
| 120 | outflow tract septum morphogenesis (GO:0003148) | 3.25648443 |
| 121 | amino-acid betaine transport (GO:0015838) | 3.25513980 |
| 122 | carnitine transport (GO:0015879) | 3.25513980 |
| 123 | muscle system process (GO:0003012) | 3.23641461 |
| 124 | striated muscle adaptation (GO:0014888) | 3.22325385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.41053572 |
| 2 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.86237950 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 5.09208686 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.54035012 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.47076675 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.47076675 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.99242432 |
| 8 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.95287051 |
| 9 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.42783013 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.41061552 |
| 11 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.99544674 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.84556102 |
| 13 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.68643223 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.65101468 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.63757090 |
| 16 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.22441111 |
| 17 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.07440120 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.05533641 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.98824179 |
| 20 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.89915116 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.85774961 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.83174975 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75254945 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74028204 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.72508047 |
| 26 | VDR_22108803_ChIP-Seq_LS180_Human | 1.65138764 |
| 27 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.63468624 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59192632 |
| 29 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.58250215 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.57109291 |
| 31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55051105 |
| 32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.51591057 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.45728663 |
| 34 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.44705846 |
| 35 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.42449691 |
| 36 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.39287143 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33305174 |
| 38 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.32080383 |
| 39 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.31656522 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25555580 |
| 41 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.25521303 |
| 42 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.24339623 |
| 43 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24281911 |
| 44 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.23698623 |
| 45 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.23698623 |
| 46 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21972783 |
| 47 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.21341452 |
| 48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19966308 |
| 49 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.18768676 |
| 50 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.18720761 |
| 51 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17091483 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.16693886 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16483788 |
| 54 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16315891 |
| 55 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15668897 |
| 56 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11797974 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11581791 |
| 58 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.10765641 |
| 59 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09429338 |
| 60 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.07745710 |
| 61 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07721433 |
| 62 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.07566799 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04673373 |
| 64 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.03041510 |
| 65 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.02596035 |
| 66 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01947852 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01569412 |
| 68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01521057 |
| 69 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.00133317 |
| 70 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98634897 |
| 71 | ATF3_27146783_Chip-Seq_COLON_Human | 0.97768737 |
| 72 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.97630092 |
| 73 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97175387 |
| 74 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96932861 |
| 75 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.95649030 |
| 76 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.95546779 |
| 77 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95512499 |
| 78 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95212997 |
| 79 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.94795414 |
| 80 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.94065874 |
| 81 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.93386958 |
| 82 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.93337941 |
| 83 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93191877 |
| 84 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92837617 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92255213 |
| 86 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92086436 |
| 87 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.92014417 |
| 88 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.91869833 |
| 89 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.91785806 |
| 90 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91312972 |
| 91 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91270294 |
| 92 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91225675 |
| 93 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90806163 |
| 94 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.90224333 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89726149 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89726149 |
| 97 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.89541308 |
| 98 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.89352999 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89321352 |
| 100 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.89305593 |
| 101 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88913393 |
| 102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88112171 |
| 103 | TBL1_22424771_ChIP-Seq_293T_Human | 0.87440215 |
| 104 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.87365041 |
| 105 | CJUN_26792858_Chip-Seq_BT549_Human | 0.86608862 |
| 106 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.86181562 |
| 107 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85647643 |
| 108 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.85549428 |
| 109 | TCF4_23295773_ChIP-Seq_U87_Human | 0.85222758 |
| 110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.85154476 |
| 111 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.84766796 |
| 112 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.84320325 |
| 113 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84059708 |
| 114 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83874037 |
| 115 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.83417536 |
| 116 | * GF1_26923725_Chip-Seq_HPCs_Mouse | 0.82711884 |
| 117 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81946352 |
| 118 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.81836035 |
| 119 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.81787887 |
| 120 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.80586710 |
| 121 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.80343625 |
| 122 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.79587838 |
| 123 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.79454498 |
| 124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79267820 |
| 125 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79105628 |
| 126 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.79099928 |
| 127 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.77470554 |
| 128 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.76940696 |
| 129 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.76918891 |
| 130 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.75077819 |
| 131 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.73893342 |
| 132 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.73786586 |
| 133 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73535383 |
| 134 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.72879972 |
| 135 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.71835109 |
| 136 | P68_20966046_ChIP-Seq_HELA_Human | 0.71492457 |
| 137 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.71228158 |
| 138 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.69943514 |
| 139 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.69836405 |
| 140 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.69241387 |
| 141 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.69032600 |
| 142 | SPI1_23127762_ChIP-Seq_K562_Human | 0.68377643 |
| 143 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.67833034 |
| 144 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.67814959 |
| 145 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.67697618 |
| 146 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.67067131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.62191048 |
| 2 | MP0004084_abnormal_cardiac_muscle | 6.41658705 |
| 3 | MP0003646_muscle_fatigue | 5.04250240 |
| 4 | MP0004215_abnormal_myocardial_fiber | 4.83961419 |
| 5 | MP0000751_myopathy | 4.77583383 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.54040029 |
| 7 | MP0005330_cardiomyopathy | 4.14095737 |
| 8 | MP0000749_muscle_degeneration | 4.05334736 |
| 9 | MP0002972_abnormal_cardiac_muscle | 3.47199293 |
| 10 | MP0008775_abnormal_heart_ventricle | 3.27236110 |
| 11 | MP0004087_abnormal_muscle_fiber | 3.11493434 |
| 12 | MP0003137_abnormal_impulse_conducting | 3.06010365 |
| 13 | MP0010630_abnormal_cardiac_muscle | 2.83052437 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.80961277 |
| 15 | MP0005385_cardiovascular_system_phenoty | 2.80365505 |
| 16 | MP0001544_abnormal_cardiovascular_syste | 2.80365505 |
| 17 | MP0006138_congestive_heart_failure | 2.62868494 |
| 18 | MP0000750_abnormal_muscle_regeneration | 2.56369658 |
| 19 | MP0003828_pulmonary_edema | 2.49610917 |
| 20 | MP0004484_altered_response_of | 2.44495647 |
| 21 | MP0002106_abnormal_muscle_physiology | 2.43292239 |
| 22 | MP0004085_abnormal_heartbeat | 2.31749832 |
| 23 | MP0003221_abnormal_cardiomyocyte_apopto | 2.24386938 |
| 24 | MP0002269_muscular_atrophy | 2.20978010 |
| 25 | MP0004510_myositis | 2.19524751 |
| 26 | MP0004130_abnormal_muscle_cell | 2.16205063 |
| 27 | MP0004145_abnormal_muscle_electrophysio | 2.04420285 |
| 28 | MP0005369_muscle_phenotype | 1.94571029 |
| 29 | MP0002127_abnormal_cardiovascular_syste | 1.89818501 |
| 30 | MP0000759_abnormal_skeletal_muscle | 1.78655250 |
| 31 | MP0000747_muscle_weakness | 1.75402809 |
| 32 | MP0003950_abnormal_plasma_membrane | 1.74696163 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.72428047 |
| 34 | MP0004233_abnormal_muscle_weight | 1.65337493 |
| 35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.64502731 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.32439884 |
| 37 | MP0000266_abnormal_heart_morphology | 1.26894164 |
| 38 | MP0003279_aneurysm | 1.21006750 |
| 39 | MP0010368_abnormal_lymphatic_system | 1.15768590 |
| 40 | MP0005666_abnormal_adipose_tissue | 1.14995735 |
| 41 | MP0000343_altered_response_to | 1.13800616 |
| 42 | MP0005451_abnormal_body_composition | 1.06636337 |
| 43 | MP0002234_abnormal_pharynx_morphology | 1.03887759 |
| 44 | MP0006035_abnormal_mitochondrial_morpho | 1.02093554 |
| 45 | MP0005165_increased_susceptibility_to | 1.00986269 |
| 46 | MP0005670_abnormal_white_adipose | 0.99303241 |
| 47 | MP0001661_extended_life_span | 0.93841445 |
| 48 | MP0003566_abnormal_cell_adhesion | 0.91281083 |
| 49 | MP0000230_abnormal_systemic_arterial | 0.86677041 |
| 50 | MP0002128_abnormal_blood_circulation | 0.86590272 |
| 51 | MP0004272_abnormal_basement_membrane | 0.81344522 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 0.76601045 |
| 53 | MP0005266_abnormal_metabolism | 0.76239823 |
| 54 | MP0005375_adipose_tissue_phenotype | 0.74252242 |
| 55 | MP0005623_abnormal_meninges_morphology | 0.71417247 |
| 56 | MP0000767_abnormal_smooth_muscle | 0.71167484 |
| 57 | MP0004185_abnormal_adipocyte_glucose | 0.69997053 |
| 58 | MP0008004_abnormal_stomach_pH | 0.69859709 |
| 59 | MP0003705_abnormal_hypodermis_morpholog | 0.68685651 |
| 60 | MP0002108_abnormal_muscle_morphology | 0.65804627 |
| 61 | MP0001879_abnormal_lymphatic_vessel | 0.65276317 |
| 62 | MP0003984_embryonic_growth_retardation | 0.59555553 |
| 63 | MP0002088_abnormal_embryonic_growth/wei | 0.58830850 |
| 64 | MP0002925_abnormal_cardiovascular_devel | 0.58814033 |
| 65 | MP0009384_cardiac_valve_regurgitation | 0.56782222 |
| 66 | MP0008438_abnormal_cutaneous_collagen | 0.54795094 |
| 67 | MP0004147_increased_porphyrin_level | 0.51714455 |
| 68 | MP0003045_fibrosis | 0.51527948 |
| 69 | MP0000733_abnormal_muscle_development | 0.48959754 |
| 70 | MP0002909_abnormal_adrenal_gland | 0.46815538 |
| 71 | MP0001784_abnormal_fluid_regulation | 0.45810012 |
| 72 | MP0001614_abnormal_blood_vessel | 0.44693799 |
| 73 | MP0000003_abnormal_adipose_tissue | 0.43790727 |
| 74 | MP0004043_abnormal_pH_regulation | 0.42220060 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 0.42205535 |
| 76 | MP0000013_abnormal_adipose_tissue | 0.40867772 |
| 77 | MP0005187_abnormal_penis_morphology | 0.40561033 |
| 78 | MP0002638_abnormal_pupillary_reflex | 0.39469309 |
| 79 | MP0005275_abnormal_skin_tensile | 0.38266254 |
| 80 | MP0003122_maternal_imprinting | 0.37416260 |
| 81 | MP0005380_embryogenesis_phenotype | 0.36394814 |
| 82 | MP0001672_abnormal_embryogenesis/_devel | 0.36394814 |
| 83 | MP0005409_darkened_coat_color | 0.35034091 |
| 84 | MP0002078_abnormal_glucose_homeostasis | 0.33920766 |
| 85 | MP0001984_abnormal_olfaction | 0.33903758 |
| 86 | MP0005595_abnormal_vascular_smooth | 0.33690719 |
| 87 | MP0002971_abnormal_brown_adipose | 0.32775212 |
| 88 | MP0003948_abnormal_gas_homeostasis | 0.32526666 |
| 89 | MP0008569_lethality_at_weaning | 0.31633230 |
| 90 | MP0003878_abnormal_ear_physiology | 0.28564037 |
| 91 | MP0005377_hearing/vestibular/ear_phenot | 0.28564037 |
| 92 | MP0003941_abnormal_skin_development | 0.27935289 |
| 93 | MP0008874_decreased_physiological_sensi | 0.27591208 |
| 94 | MP0001727_abnormal_embryo_implantation | 0.25981031 |
| 95 | MP0005388_respiratory_system_phenotype | 0.24292301 |
| 96 | MP0002133_abnormal_respiratory_system | 0.24292301 |
| 97 | MP0001299_abnormal_eye_distance/ | 0.23136972 |
| 98 | MP0003136_yellow_coat_color | 0.22542208 |
| 99 | MP0005535_abnormal_body_temperature | 0.20918596 |
| 100 | MP0000249_abnormal_blood_vessel | 0.20909531 |
| 101 | MP0008961_abnormal_basal_metabolism | 0.20235287 |
| 102 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.19872691 |
| 103 | MP0000579_abnormal_nail_morphology | 0.18899814 |
| 104 | MP0002102_abnormal_ear_morphology | 0.18456012 |
| 105 | MP0003091_abnormal_cell_migration | 0.16837350 |
| 106 | MP0005376_homeostasis/metabolism_phenot | 0.16729908 |
| 107 | MP0002295_abnormal_pulmonary_circulatio | 0.16649077 |
| 108 | MP0005386_behavior/neurological_phenoty | 0.16597334 |
| 109 | MP0004924_abnormal_behavior | 0.16597334 |
| 110 | MP0002933_joint_inflammation | 0.16289493 |
| 111 | MP0005334_abnormal_fat_pad | 0.15979987 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.15850685 |
| 113 | MP0000462_abnormal_digestive_system | 0.15737366 |
| 114 | MP0001175_abnormal_lung_morphology | 0.15663507 |
| 115 | MP0001697_abnormal_embryo_size | 0.15290596 |
| 116 | MP0001958_emphysema | 0.15247114 |
| 117 | MP0005503_abnormal_tendon_morphology | 0.14375879 |
| 118 | MP0003935_abnormal_craniofacial_develop | 0.14213904 |
| 119 | MP0009115_abnormal_fat_cell | 0.12897840 |
| 120 | MP0001529_abnormal_vocalization | 0.11205716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.58929204 |
| 2 | Ventricular tachycardia (HP:0004756) | 7.18222401 |
| 3 | Atrial fibrillation (HP:0005110) | 6.53971121 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 6.31790449 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 6.14668003 |
| 6 | Primary atrial arrhythmia (HP:0001692) | 6.10740422 |
| 7 | Supraventricular tachycardia (HP:0004755) | 5.91273705 |
| 8 | Lipoatrophy (HP:0100578) | 5.80425802 |
| 9 | Supraventricular arrhythmia (HP:0005115) | 5.79583448 |
| 10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.69014693 |
| 11 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.61746236 |
| 12 | Subaortic stenosis (HP:0001682) | 5.61746236 |
| 13 | Exercise-induced myalgia (HP:0003738) | 5.61084852 |
| 14 | Abnormality of the calf musculature (HP:0001430) | 5.30392280 |
| 15 | Right ventricular cardiomyopathy (HP:0011663) | 5.15736010 |
| 16 | Syncope (HP:0001279) | 5.11724936 |
| 17 | Muscle fiber splitting (HP:0003555) | 5.08253087 |
| 18 | Myoglobinuria (HP:0002913) | 4.83597786 |
| 19 | Dilated cardiomyopathy (HP:0001644) | 4.73854340 |
| 20 | Hyporeflexia of lower limbs (HP:0002600) | 4.72870385 |
| 21 | Palpitations (HP:0001962) | 4.67409110 |
| 22 | Prolonged QT interval (HP:0001657) | 4.62259139 |
| 23 | Ventricular arrhythmia (HP:0004308) | 4.43788969 |
| 24 | Bundle branch block (HP:0011710) | 4.40357414 |
| 25 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.16458834 |
| 26 | Asymmetric septal hypertrophy (HP:0001670) | 4.06195169 |
| 27 | EMG: myopathic abnormalities (HP:0003458) | 4.05854081 |
| 28 | Muscle fiber inclusion bodies (HP:0100299) | 4.04240572 |
| 29 | Ventricular fibrillation (HP:0001663) | 3.96202806 |
| 30 | Rhabdomyolysis (HP:0003201) | 3.80153739 |
| 31 | Heart block (HP:0012722) | 3.78765078 |
| 32 | Atrioventricular block (HP:0001678) | 3.74898186 |
| 33 | Abnormal atrioventricular conduction (HP:0005150) | 3.56533659 |
| 34 | Nemaline bodies (HP:0003798) | 3.50364720 |
| 35 | Increased connective tissue (HP:0009025) | 3.39296114 |
| 36 | Abnormal EKG (HP:0003115) | 3.34164092 |
| 37 | Left ventricular hypertrophy (HP:0001712) | 3.19426265 |
| 38 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.09961533 |
| 39 | Hepatic necrosis (HP:0002605) | 3.09168661 |
| 40 | Myotonia (HP:0002486) | 3.08546664 |
| 41 | Acute necrotizing encephalopathy (HP:0006965) | 3.07593274 |
| 42 | Difficulty running (HP:0009046) | 2.86108905 |
| 43 | Palmoplantar keratoderma (HP:0000982) | 2.86079546 |
| 44 | Ragged-red muscle fibers (HP:0003200) | 2.82020258 |
| 45 | Bradycardia (HP:0001662) | 2.67165667 |
| 46 | Hepatocellular necrosis (HP:0001404) | 2.66601194 |
| 47 | Hypoglycemic coma (HP:0001325) | 2.62647047 |
| 48 | Conjunctival hamartoma (HP:0100780) | 2.62361649 |
| 49 | Distal lower limb muscle weakness (HP:0009053) | 2.59851597 |
| 50 | Acute encephalopathy (HP:0006846) | 2.59437394 |
| 51 | Ketoacidosis (HP:0001993) | 2.57232425 |
| 52 | Hypoplastic heart (HP:0001961) | 2.56769697 |
| 53 | Distal lower limb amyotrophy (HP:0008944) | 2.56677498 |
| 54 | Mitochondrial inheritance (HP:0001427) | 2.53559253 |
| 55 | Progressive macrocephaly (HP:0004481) | 2.51762164 |
| 56 | Congenital malformation of the right heart (HP:0011723) | 2.47342376 |
| 57 | Double outlet right ventricle (HP:0001719) | 2.47342376 |
| 58 | Difficulty climbing stairs (HP:0003551) | 2.46296288 |
| 59 | Increased CSF lactate (HP:0002490) | 2.43850379 |
| 60 | Neck muscle weakness (HP:0000467) | 2.38276331 |
| 61 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.34702549 |
| 62 | Exercise intolerance (HP:0003546) | 2.34465895 |
| 63 | Pheochromocytoma (HP:0002666) | 2.33819949 |
| 64 | Increased muscle lipid content (HP:0009058) | 2.33725284 |
| 65 | Cerebral edema (HP:0002181) | 2.33302587 |
| 66 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.30112542 |
| 67 | Dicarboxylic aciduria (HP:0003215) | 2.30112542 |
| 68 | Neoplasm of the adrenal gland (HP:0100631) | 2.28713897 |
| 69 | Type 1 muscle fiber predominance (HP:0003803) | 2.25815319 |
| 70 | Muscle stiffness (HP:0003552) | 2.24344594 |
| 71 | Areflexia of lower limbs (HP:0002522) | 2.22211594 |
| 72 | Sudden cardiac death (HP:0001645) | 2.21280776 |
| 73 | Abnormality of the tricuspid valve (HP:0001702) | 2.17452671 |
| 74 | Abnormality of the foot musculature (HP:0001436) | 2.16981225 |
| 75 | Congestive heart failure (HP:0001635) | 2.14425521 |
| 76 | Limb-girdle muscle atrophy (HP:0003797) | 2.13497461 |
| 77 | Scapular winging (HP:0003691) | 2.13056117 |
| 78 | Lactic acidosis (HP:0003128) | 2.13032265 |
| 79 | Steppage gait (HP:0003376) | 2.12899857 |
| 80 | Neuroendocrine neoplasm (HP:0100634) | 2.10554091 |
| 81 | Respiratory failure (HP:0002878) | 2.09001589 |
| 82 | Increased serum pyruvate (HP:0003542) | 2.08509074 |
| 83 | Abnormality of glycolysis (HP:0004366) | 2.08509074 |
| 84 | Increased intramyocellular lipid droplets (HP:0012240) | 2.06096617 |
| 85 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.05841637 |
| 86 | Increased variability in muscle fiber diameter (HP:0003557) | 2.05599053 |
| 87 | Hypoplastic left heart (HP:0004383) | 2.03003633 |
| 88 | Dysmetric saccades (HP:0000641) | 2.02050257 |
| 89 | Frequent falls (HP:0002359) | 2.01662597 |
| 90 | Muscular dystrophy (HP:0003560) | 2.00304451 |
| 91 | Generalized muscle weakness (HP:0003324) | 1.99751326 |
| 92 | Testicular atrophy (HP:0000029) | 1.99120477 |
| 93 | Hamartoma of the eye (HP:0010568) | 1.98538715 |
| 94 | Lower limb amyotrophy (HP:0007210) | 1.97499293 |
| 95 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.97047591 |
| 96 | EMG: neuropathic changes (HP:0003445) | 1.96785404 |
| 97 | Rimmed vacuoles (HP:0003805) | 1.94094878 |
| 98 | Abnormality of the endocardium (HP:0004306) | 1.92881770 |
| 99 | Foot dorsiflexor weakness (HP:0009027) | 1.91776366 |
| 100 | Esophageal neoplasm (HP:0100751) | 1.90749786 |
| 101 | Neoplasm of head and neck (HP:0012288) | 1.90749786 |
| 102 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.87501172 |
| 103 | Abnormality of alanine metabolism (HP:0010916) | 1.87501172 |
| 104 | Hyperalaninemia (HP:0003348) | 1.87501172 |
| 105 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.86210603 |
| 106 | Diaphragmatic weakness (HP:0009113) | 1.83292665 |
| 107 | Periauricular skin pits (HP:0100277) | 1.82705137 |
| 108 | Preauricular pit (HP:0004467) | 1.82705137 |
| 109 | Generalized aminoaciduria (HP:0002909) | 1.81398821 |
| 110 | Patent foramen ovale (HP:0001655) | 1.79711953 |
| 111 | Ketosis (HP:0001946) | 1.78897098 |
| 112 | Pulmonary artery stenosis (HP:0004415) | 1.77900398 |
| 113 | Lipid accumulation in hepatocytes (HP:0006561) | 1.76278408 |
| 114 | Bulbar palsy (HP:0001283) | 1.76135582 |
| 115 | Tinnitus (HP:0000360) | 1.74970753 |
| 116 | Resting tremor (HP:0002322) | 1.74823224 |
| 117 | Progressive muscle weakness (HP:0003323) | 1.73092106 |
| 118 | Multiple enchondromatosis (HP:0005701) | 1.72205953 |
| 119 | Large for gestational age (HP:0001520) | 1.72042708 |
| 120 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.71426461 |
| 121 | Skin pits (HP:0100276) | 1.70881684 |
| 122 | Gowers sign (HP:0003391) | 1.70178674 |
| 123 | Hip contracture (HP:0003273) | 1.68131296 |
| 124 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.60789701 |
| 125 | Transposition of the great arteries (HP:0001669) | 1.60789701 |
| 126 | Abnormal connection of the cardiac segments (HP:0011545) | 1.60789701 |
| 127 | Myopathic facies (HP:0002058) | 1.58231552 |
| 128 | Waddling gait (HP:0002515) | 1.48668447 |
| 129 | Proximal amyotrophy (HP:0007126) | 1.48642765 |
| 130 | Aplasia of the musculature (HP:0100854) | 1.45652427 |
| 131 | Skin nodule (HP:0200036) | 1.43835616 |
| 132 | Lymphangioma (HP:0100764) | 1.42094918 |
| 133 | Toxemia of pregnancy (HP:0100603) | 1.40067972 |
| 134 | Late onset (HP:0003584) | 1.39059681 |
| 135 | Maternal diabetes (HP:0009800) | 1.35717839 |
| 136 | Aneurysm (HP:0002617) | 1.35624698 |
| 137 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.35028366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.20641656 |
| 2 | OBSCN | 5.15402067 |
| 3 | MYLK | 4.88809594 |
| 4 | LMTK2 | 3.72198463 |
| 5 | PKN2 | 3.52267574 |
| 6 | PHKG1 | 3.50320167 |
| 7 | PHKG2 | 3.50320167 |
| 8 | PDK4 | 3.20337518 |
| 9 | PDK3 | 3.20337518 |
| 10 | DMPK | 3.16011819 |
| 11 | STK24 | 3.03678559 |
| 12 | PIK3CA | 2.63498779 |
| 13 | TRIB3 | 2.52019774 |
| 14 | NEK1 | 2.33296303 |
| 15 | BCKDK | 2.29326769 |
| 16 | MUSK | 2.27344309 |
| 17 | TIE1 | 2.15241152 |
| 18 | PDK2 | 1.89004871 |
| 19 | ZAK | 1.64985113 |
| 20 | ILK | 1.59672930 |
| 21 | STK38L | 1.56968754 |
| 22 | PINK1 | 1.54153486 |
| 23 | EPHA3 | 1.52795329 |
| 24 | MARK1 | 1.49981687 |
| 25 | CDC42BPA | 1.43387865 |
| 26 | PAK3 | 1.40595351 |
| 27 | GRK7 | 1.33371302 |
| 28 | CAMK2D | 1.25975577 |
| 29 | STK4 | 1.25861173 |
| 30 | PRKD1 | 1.23760753 |
| 31 | TRPM7 | 1.16228397 |
| 32 | ROCK1 | 1.13323886 |
| 33 | FLT3 | 1.08716000 |
| 34 | WNK4 | 1.08137521 |
| 35 | DAPK3 | 1.01709458 |
| 36 | MAP3K5 | 0.89690952 |
| 37 | MAPK12 | 0.88783971 |
| 38 | MAP3K6 | 0.85366665 |
| 39 | PIK3CG | 0.85014947 |
| 40 | MAP3K7 | 0.84182268 |
| 41 | PRKAA1 | 0.80193387 |
| 42 | MAPKAPK3 | 0.78881696 |
| 43 | RIPK1 | 0.75756664 |
| 44 | PRKAA2 | 0.75696954 |
| 45 | PTK2B | 0.70549234 |
| 46 | MAPK4 | 0.70350900 |
| 47 | KDR | 0.69503799 |
| 48 | PKN1 | 0.69314642 |
| 49 | CAMK4 | 0.68722099 |
| 50 | INSRR | 0.68033075 |
| 51 | MAPK7 | 0.65467578 |
| 52 | MAP2K3 | 0.65004900 |
| 53 | CAMK1 | 0.64231365 |
| 54 | ROCK2 | 0.64039903 |
| 55 | PDGFRA | 0.62389695 |
| 56 | RPS6KL1 | 0.60941438 |
| 57 | RPS6KC1 | 0.60941438 |
| 58 | STK38 | 0.60457532 |
| 59 | MAP3K3 | 0.59081305 |
| 60 | CAMK2A | 0.58210738 |
| 61 | WNK1 | 0.57766855 |
| 62 | TGFBR2 | 0.53266737 |
| 63 | RPS6KA6 | 0.51550653 |
| 64 | CAMK2B | 0.51346672 |
| 65 | LIMK1 | 0.51034174 |
| 66 | PRKACB | 0.50715946 |
| 67 | NEK9 | 0.49537958 |
| 68 | NLK | 0.49161658 |
| 69 | STK39 | 0.47784209 |
| 70 | ITK | 0.47055224 |
| 71 | MAP2K1 | 0.44448051 |
| 72 | PRKD3 | 0.43557822 |
| 73 | DDR2 | 0.41128683 |
| 74 | PRKCE | 0.39536252 |
| 75 | PRKACA | 0.37695252 |
| 76 | KSR2 | 0.35895094 |
| 77 | BLK | 0.35439003 |
| 78 | PRKACG | 0.34563450 |
| 79 | MAP3K10 | 0.32841585 |
| 80 | AKT2 | 0.30508780 |
| 81 | CAMK2G | 0.30476768 |
| 82 | STK11 | 0.30068482 |
| 83 | ZAP70 | 0.29714976 |
| 84 | EPHB2 | 0.29637418 |
| 85 | FGFR4 | 0.29537122 |
| 86 | ICK | 0.27961229 |
| 87 | LATS1 | 0.26622727 |
| 88 | MARK3 | 0.25917729 |
| 89 | PTK6 | 0.24470530 |
| 90 | PRKCH | 0.24176121 |
| 91 | NME2 | 0.24084052 |
| 92 | PDPK1 | 0.23735750 |
| 93 | FGFR3 | 0.22949531 |
| 94 | RPS6KA1 | 0.22918026 |
| 95 | MARK2 | 0.22135577 |
| 96 | PRKG2 | 0.22074208 |
| 97 | LATS2 | 0.21829956 |
| 98 | PDK1 | 0.21665933 |
| 99 | DYRK1B | 0.21234194 |
| 100 | KSR1 | 0.20902177 |
| 101 | EPHB1 | 0.20347451 |
| 102 | SGK2 | 0.20088772 |
| 103 | PRKG1 | 0.19952122 |
| 104 | MAPK10 | 0.19925791 |
| 105 | LRRK2 | 0.19022032 |
| 106 | TESK1 | 0.16643797 |
| 107 | PAK2 | 0.15873411 |
| 108 | ADRBK1 | 0.14958754 |
| 109 | MTOR | 0.14034340 |
| 110 | SIK1 | 0.13957093 |
| 111 | PRKCQ | 0.12781759 |
| 112 | RET | 0.12603711 |
| 113 | SGK3 | 0.12108030 |
| 114 | STK3 | 0.12002790 |
| 115 | RPS6KA2 | 0.11770768 |
| 116 | MAPKAPK2 | 0.11708084 |
| 117 | RPS6KA3 | 0.08653965 |
| 118 | JAK1 | 0.08094104 |
| 119 | FER | 0.08092335 |
| 120 | SGK1 | 0.08058798 |
| 121 | TGFBR1 | 0.07639787 |
| 122 | FGFR1 | 0.07105068 |
| 123 | UHMK1 | 0.06314623 |
| 124 | CDK4 | 0.06238308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.17549419 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.77695206 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.34515187 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.96226305 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.91896472 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 3.46847291 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.32031237 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.07057125 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.95645805 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.73800227 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.60229227 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.46943322 |
| 13 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.42718026 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.23829235 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 2.22363679 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.08740494 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.06605241 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.88634241 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.81403474 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.69143533 |
| 21 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.53680670 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.48528143 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32079561 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27203402 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.18119923 |
| 26 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07505394 |
| 27 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.01518568 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.98008441 |
| 29 | Insulin resistance_Homo sapiens_hsa04931 | 0.95982916 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.95844789 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94785184 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.91666948 |
| 33 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.86277200 |
| 34 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84344828 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84222663 |
| 36 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77847191 |
| 37 | Focal adhesion_Homo sapiens_hsa04510 | 0.75787959 |
| 38 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74339872 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 0.70231434 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68863445 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67757330 |
| 42 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65092304 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.65016845 |
| 44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64424002 |
| 45 | Tight junction_Homo sapiens_hsa04530 | 0.64361301 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62415393 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62229305 |
| 48 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57816835 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54968185 |
| 50 | GABAergic synapse_Homo sapiens_hsa04727 | 0.54942351 |
| 51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54523060 |
| 52 | Morphine addiction_Homo sapiens_hsa05032 | 0.54069092 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 0.53846903 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53271864 |
| 55 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51366419 |
| 56 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.50188612 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49931454 |
| 58 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47447617 |
| 59 | Taste transduction_Homo sapiens_hsa04742 | 0.45555916 |
| 60 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.45145846 |
| 61 | Adherens junction_Homo sapiens_hsa04520 | 0.41677157 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.41080175 |
| 63 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.40531429 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35734338 |
| 65 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.35342794 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34010454 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33658696 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33479704 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33203153 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32642043 |
| 71 | Melanogenesis_Homo sapiens_hsa04916 | 0.32602563 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32521666 |
| 73 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31813273 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30996436 |
| 75 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30300070 |
| 76 | Renin secretion_Homo sapiens_hsa04924 | 0.29586129 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.28613758 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.28243170 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.27733284 |
| 80 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.27511790 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27509825 |
| 82 | Cocaine addiction_Homo sapiens_hsa05030 | 0.26164691 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26029201 |
| 84 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25859480 |
| 85 | Long-term potentiation_Homo sapiens_hsa04720 | 0.24740728 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23572416 |
| 87 | Insulin secretion_Homo sapiens_hsa04911 | 0.22860308 |
| 88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.22502771 |
| 89 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21593599 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.21285622 |
| 91 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.21119393 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19006157 |
| 93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.18366882 |
| 94 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.18246253 |
| 95 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.16014135 |
| 96 | Circadian entrainment_Homo sapiens_hsa04713 | 0.15662305 |
| 97 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.15554840 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.15397977 |
| 99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.11537156 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.11436613 |
| 101 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.11139289 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.10657692 |
| 103 | Platelet activation_Homo sapiens_hsa04611 | 0.09977121 |
| 104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.09454847 |
| 105 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.06083408 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.05288971 |
| 107 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.04236462 |
| 108 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.01553836 |
| 109 | Gap junction_Homo sapiens_hsa04540 | 0.00829873 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.00826698 |
| 111 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.00795729 |
| 112 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.00466972 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0522998 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.0501934 |
| 115 | Bile secretion_Homo sapiens_hsa04976 | -0.0467191 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | -0.0459973 |
| 117 | Cholinergic synapse_Homo sapiens_hsa04725 | -0.0320268 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0173820 |
| 119 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0151414 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | -0.0080608 |
| 121 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0048537 |
| 122 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0022445 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | -0.0005889 |

